I Paid $300 for DNA-based fitness advice and all I got was junk science
By Angela Chen,
The Verge
| 11. 20. 2017
In January of this year, I decided I would complete a half-marathon. I would push my body to the limit and be reborn as my best self. For months, I woke up at 6 to run before work, motivated by the promise of sweet endorphins and even-sweeter self-righteousness. But then the winter wore on, and I gained some weight, and now I’m back to 5Ks instead.
In my quest to return to former glory, I redownloaded the “couch to half-marathon” app and spent $100 on a pair of New Balance shoes. I became interested in a genetic-testing kit that promised to provide the information I needed to complete 13.1 miles once and for all.
Genetic testing for wellness seems like a natural choice for someone like me. I still wear my Fitbit every day two years after getting it, making me one of the few and the proud that have stuck with their device for longer than six months. I own a smart scale and a running watch; I track calories and read training forums. But the forum...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...